tiprankstipranks
Protagenic Therapeutics (PTIX)
NASDAQ:PTIX
Holding PTIX?
Track your performance easily

Protagenic Therapeutics (PTIX) Ownership - Who Owns Protagenic Therapeutics?

31 Followers

Protagenic Therapeutics (PTIX) Ownership Overview

6.71%0.89%0.28%0.47%91.65%
6.71%
Insiders
0.28% Other Institutional Investors
0.47% ETFs
91.65% Public Companies and
Individual Investors
The ownership structure of Protagenic Therapeutics (PTIX) stock is a mix of institutional, retail, and individual investors. Approximately 1.64% of the company’s stock is owned by Institutional Investors, 6.71% is owned by Insiders, and 91.65% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
410,000Insider6.03%253,380
45,815Insider0.67%28,314
31,996Institution0.47%19,774
31,996Institution0.47%19,774
28,601Institution0.42%17,675

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
31,996Institution0.47%19,774
28,601Institution0.42%17,675

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
31,996Institution0.47%20,317

FAQ

Who Owns Protagenic Therapeutics (PTIX)?
According to the latest TipRanks data, approximately 0.28% of the company's stock is held by institutional investors, 6.71% is held by insiders, and 91.65% is held by retail investors.
    What percentage of Protagenic Therapeutics (PTIX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.28% of Protagenic Therapeutics (PTIX) stock is held by institutional investors.
      What percentage of Protagenic Therapeutics (PTIX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 91.65% of Protagenic Therapeutics (PTIX) stock is held by retail investors.
        Who owns the most shares of Protagenic Therapeutics (PTIX)?
        Khalil Barrage owns the most shares of Protagenic Therapeutics (PTIX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis